Moreover, it reduced the levels of phosphorylated AKT and p70S6K in a dose- and time-dependent manner, indicating that YYN-37′s anti-tumor efficacy is mediated through the suppression of PI3K and mTOR kinase activities [20]. The gene discussed is MTOR; the disease is neoplasm.